Sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder
ICD-10 F13.982 is a billable code used to indicate a diagnosis of sedative, hypnotic or anxiolytic use, unspecified with sedative, hypnotic or anxiolytic-induced sleep disorder.
F13.982 refers to a condition characterized by the use of sedative, hypnotic, or anxiolytic substances that leads to a sleep disorder. This code is applicable when the specific substance used is not identified, but the patient exhibits symptoms of a sleep disorder induced by these substances. Patients may present with insomnia, excessive daytime sleepiness, or other sleep disturbances that are directly linked to their use of these medications. The condition is often seen in individuals with a history of substance use disorders, where the sedative effects of these drugs can lead to dependency and withdrawal symptoms. Treatment typically involves a multidisciplinary approach, including behavioral therapies, medication management, and support groups to address both the substance use and the resultant sleep disorder. Accurate coding is crucial for appropriate treatment planning and reimbursement.
Detailed patient history including substance use, mental health status, and sleep patterns.
Patients presenting with anxiety or insomnia related to substance use.
Consideration of co-occurring mental health disorders and their impact on treatment.
Sleep studies and assessments to confirm sleep disorders.
Patients with chronic insomnia linked to sedative use.
Differentiating between primary sleep disorders and those induced by substance use.
Used for follow-up visits for patients with substance use and sleep disorders.
Document the patient's substance use history and sleep complaints.
Psychiatric evaluation may require additional documentation.
F13.982 is significant as it captures the complexities of substance use and its impact on sleep, allowing for targeted treatment and better understanding of patient needs.
